Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Postpones Sunscreen Innovation Act - Happi
Company News, Regulations

FDA Postpones Sunscreen Innovation Act

Agency still combing through public comments.

It's not happening…yet.  The Sunscreen Innovation Act (SIA) was scheduled to go into effect yesterday, per passage of the Act back in 2014. But according to industry sources, the US Food and Drug Administration is postponing implementation. 

“Our understanding is that the FDA has indicated a delay until September 2020 to finalize the sunscreen monograph,” explained Lisa Powers, EVP-public affairs & communications, Personal Care Products Council. “Apparently, the Agency received a significant amount of public comments and is still going through them.”

The Act was enacted on November 26, 2014 to provide an alternative process for the review of safety and effectiveness of nonprescription sunscreen active ingredients.

The SIA supplements the FDA’s Time and Extent Application (TEA) regulation with new statutory procedures. The SIA also requires FDA to establish timeframes for review of TEAs for OTC drugs other than sunscreen active ingredients.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters